Affimed NV (LTS:0HL9)
$ 2.22 -0.177 (-7.38%) Market Cap: 38.03 Mil Enterprise Value: 25.31 Mil PE Ratio: 0 PB Ratio: 1.84 GF Score: 26/100

Q2 2024 Affimed NV Earnings Call Transcript

Sep 05, 2024 / 12:30PM GMT
Release Date Price: $3.81 (-1.06%)
Operator

Good day, everyone, and welcome to Affimed Second-Quarter 2024 Earnings and Corporate Update Call. (Operator Instructions) You will then have an automatic message advising your hand is raised. As a reminder, today's conference call is being recorded.

I would now like to introduce your host for today's call, Alexander Fudukidis, Head of Investor Relations at Affimed . Please go ahead.

Alexander Fudukidis
Affimed NV - Investor Relations

Thank you, Olivia, and thank you all for joining us today for our second quarter 2024 update call. Before we begin, I'd like to remind everyone that we issued the relevant press release earlier today, and that can be found on our Investor Relations section of the website. On our website, you can also find the presentation we will be using today.

On the call today, we have members of our management team, including Shawn Leland, our new Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Wolfgang Fischer, our Chief Operating Officer; Denise Mueller, our Chief Business Officer; and Harry Welten,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot